drugset / Trial / NCT00394303

Tight Intra-Operative Glucose Control During Coronary Artery Bypass Surgery

NCT00394303

Phase 4 Terminated 1400 enrolled Rabin Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

Blood glucose levels increase in response to stress, infection or other conditions faced by patients in the hospital. This occurs commonly among patients with known diabetes, but also among non-diabetic hospitalized patients. Tight glucose control, the maintenance of blood glucose levels within normal limits (80-120 mg/dl), has been shown to improve patient outcomes in the hospital in several settings, mainly among critically ill patients hospitalized in intensive care units. We plan to assess the importance of tight glucose control during open-heart surgery. The prevalence of hyperglycemia (elevated blood glucose) during this operation is high. Hyperglycemia may be associated with increased vulnerability to surgical site infections, neurological damage, cardiac and renal injury. Conversely, tight glucose control may be associated with hypoglycemia (pathologically low glucose levels) that may results in neurological injury. We hypothesize that tight glucose control will improve patient outcomes following surgery.

Timeline

Start
2007-02
Primary completion
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic